Updated:
Trius Therapeutics Inc
Trius Therapeutics Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001356857, and its reported industry...
Overview
Trius Therapeutics Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001356857, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-03-13, it reported annual revenue of USD 27,185,000; net income of USD -53,928,000; total assets of USD 75,274,000 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Trius Therapeutics Inc
- Former names in filing history
- RX3 PHARMACEUTICALS INC (2006-03-07 to 2006-10-25)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001356857
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2012USD | $27.2M | -$53.9M | $75.3M | $16.4M | -$49.5M | |
| FY2011USD | $41.0M | -$18.3M | $68.1M | $11.4M | -$13.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Trius Therapeutics Inc in Altss
Track this company’s investors, transactions and relationships in Altss.